Logo image
v-Src Oncogene Induces Trop2 Proteolytic Activation via Cyclin D1
Journal article   Open access   Peer reviewed

v-Src Oncogene Induces Trop2 Proteolytic Activation via Cyclin D1

Xiaoming Ju, Xuanmao Jiao, Adam Ertel, Mathew C Casimiro, Gabriele Di Sante, Shengqiong Deng, Zhiping Li, Agnese Di Rocco, Tingting Zhan, Adam Hawkins, …
Cancer research (Chicago, Ill.), v 76(22), pp 6723-6734
15 Nov 2016
PMID: 27634768
url
https://europepmc.org/articles/pmc5330252View
Accepted (AM)Open Access (License Unspecified) Open
url
https://doi.org/10.1158/0008-5472.CAN-15-3327View
Published, Version of Record (VoR) Open

Abstract

Animals Antigens, Neoplasm - genetics Antigens, Neoplasm - metabolism Cell Adhesion Molecules - genetics Cell Adhesion Molecules - metabolism Cyclin D1 - metabolism Humans Mice Signal Transduction src-Family Kinases - metabolism Transfection
Proteomic analysis of castration-resistant prostate cancer demonstrated the enrichment of Src tyrosine kinase activity in approximately 90% of patients. Src is known to induce cyclin D1, and a cyclin D1-regulated gene expression module predicts poor outcome in human prostate cancer. The tumor-associated calcium signal transducer 2 (TACSTD2/Trop2/M1S1) is enriched in the prostate, promoting prostate stem cell self-renewal upon proteolytic activation via a γ-secretase cleavage complex (PS1, PS2) and TACE (ADAM17), which releases the Trop2 intracellular domain (Trop2 ICD). Herein, v-Src transformation of primary murine prostate epithelial cells increased the proportion of prostate cancer stem cells as characterized by gene expression, epitope characteristics, and prostatosphere formation. Cyclin D1 was induced by v-Src, and Src kinase induction of Trop2 ICD nuclear accumulation required cyclin D1. Cyclin D1 induced abundance of the Trop2 proteolytic cleavage activation components (PS2, TACE) and restrained expression of the inhibitory component of the Trop2 proteolytic complex (Numb). Patients with prostate cancer with increased nuclear Trop2 ICD and cyclin D1, and reduced Numb, had reduced recurrence-free survival probability (HR = 4.35). Cyclin D1, therefore, serves as a transducer of v-Src-mediated induction of Trop2 ICD by enhancing abundance of the Trop2 proteolytic activation complex. Cancer Res; 76(22); 6723-34. ©2016 AACR.

Metrics

5 Record Views
19 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Oncology
Logo image